BioSpace News Archive

Celgene Corporation announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to POMALYST® (pomalidomide) for the treatment of patients with human immunodeficiency virus (HIV)-positive Kaposi sarcoma who have previously received systemic chemotherapy, as well as patients with HIV‐negative Kaposi’s sarcoma.

Employee Assistance Society of North America recognizes excellence in employee mental health support and workplace health leadership

On World Melanoma Day 2019, the Canadian Dermatology Association urges Canadians to adopt sun-safe practices that will better protect them against melanoma and other forms of skin cancer.

Centene Corporation issued a reminder that it will host an investor meeting, including a question-and-answer session, on Friday, June 14, 2019.

Peter Kunz, MD with MIAS / Advanced Laser and Cosmetic Center is implementing a non-invasive and drug-free solution for Erectile Dysfunction.

Epic Sciences, Inc. announced the launch of a new brand identity, redesigned logo, tagline and website.

Aquestive Therapeutics, Inc. announced that management will present at the 2019 RBC Capital Markets Global Healthcare Conference to be held in New York, NY on May 21-22, and the 20th Annual B.

Unchained Labs announced it has closed a $50 million debt facility from Silicon Valley Bank to further support its working capital growth, along with adding dry powder for future acquisitions.

Aurora Cannabis Inc. and Radient Technologies Inc., announced that Aurora has taken delivery of Radient’s first commercial batch of finished cannabis derivatives, from Radient’s proprietary extraction platform.

Valens GroWorks Corp. announced that Deepak Anand has been appointed to its Board of Directors as an independent member.